Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

7 results
Display

Efficacy of Levofloxacin and Rifaximin based Quadruple Therapy in Helicobacter pylori Associated Gastroduodenal Disease: A Double-Blind, Randomized Controlled Trial

Choi KH, Chung WC, Lee KM, Paik CN, Kim EJ, Kang BK, Oak JH, Jung SH

The aim of this study was to evaluate the efficacy of levofloxacin and rifaximin based quadruple regimen as first-line treatment for Helicobacter pylori infection. A prospectively randomized, double-blinded, parallel group,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Extraesophageal Manifestations of Gastroesophageal Reflux Disease

Kim GH

  • KMID: 783037
  • Korean J Gastroenterol.
  • 2008 Aug;52(2):69-79.
Gastroesophageal reflux disease (GERD) often presents as typical symptoms such as heartburn or acid regurgitation. However, a subgroup of patients presents a collection of symptoms and signs that are not...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effectiveness of 10 Day-sequential Therapy for Helicobacter pylori Eradication in Korea

Choi WH, Park DI, Oh SJ, Baek YH, Hong CH, Hong EJ, Song MJ, Park SK, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI

  • KMID: 1767527
  • Korean J Gastroenterol.
  • 2008 May;51(5):280-284.
BACKGROUND/AIMS: Antibiotic resistance and poor compliance are the main causes of Helicobacter pylori (H. pylori) eradication failure. Proton pump inhibitor (PPI)-based triple therapy is the most preferred regimen in clinical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of Anti-secretory Treatment in Addition to Helicobacter pylori Eradication Triple Therapy in the Treatment of Peptic Ulcer

Jung JM, Shim KN, Oh HJ, Na YJ, Jung HS, Jung SA, Yoo K

  • KMID: 782957
  • Korean J Gastroenterol.
  • 2008 Jan;51(1):11-18.
BACKGROUND/AIMS: It is not clear whether the anti-secretory therapy should be continued for symptomatic relief and ulcer healing before or after the eradication of H. pylori in patients with peptic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Influence of CYP2C19 Polymorphism and Helicobacter pylori Status on the Antisecretory Effect of Omeprazole in Gastroesophageal Reflux Disease

Sohn YH, Lee WS, Park CH, Joo YE, Kim HS, Choi SK, Rew JS, Kim SJ

  • KMID: 782759
  • Korean J Gastroenterol.
  • 2006 Sep;48(3):162-171.
BACKGROUND/AIMS: The acid suppressive effect of omeprazole (OMP) is influenced by the metabolic capacity of gastric acid suppression, which is dependent on CYP2C19 polymorphism. The aim of this study was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of 14 Day OBMT Therapy as a Second-line Treatment for Helicobacter pylori Infection

Park SC, Chun HJ, Jung SW, Keum B, Han WS, Choung RS, Kim YS, Jeen YT, Lee HS, Um SH, Lee SW, Choi JH, Kim CD, Ryu HS, Hyun JH

  • KMID: 1113356
  • Korean J Gastroenterol.
  • 2004 Sep;44(3):136-141.
BACKGROUND/AIMS: As a second-line treatment for H. pylori eradication in the case of first-line OAC (omeprazole, amoxicillin, clarithromycin) treatment failure, a minimum of one-week OBMT quadruple therapy composed of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Relationship between Helicobacter pylori and rosacea: it may be a myth

Herr H, You CH

Although it is debatable whether Helicobacter pylori may play a role in the pathogenesis of rosacea, some authors suggested that the treatment of H. pylori might have a beneficial effect....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr